Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancer

By Wildiers H.  

Breast Cancer Research and Treatment, Vol. 123, Iss. 2, 2010-09 ,pp. : 463-469

Springer Publishing Company

Access to resources Recommend Favorite

Amplification of TOP2A and HER-2 genes in breast cancers occurring in patients harbouring BRCA1 germline mutations

By Hagen Anne   Bofin Anna   Ytterhus Borgny   Maehle Lovise   Kjellevold Kjell   Myhre Hans   Møller Pål   Lønning Per  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 199-203

Informa Healthcare

Access to resources Recommend Favorite

Phase I–II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin–cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinoma

By Andreopoulou Eleni   Vigoda Ivette   Valero Vicente   Hershman Dawn   Raptis George   Vahdat Linda   Han Hyo   Wright John   Pellegrino Christine   Cristofanilli Massimo   Alvarez Ricardo   Fehn Karen   Fineberg Susan   Sparano Joseph  

Breast Cancer Research and Treatment, Vol. 141, Iss. 3, 2013-10 ,pp. : 429-435

Springer Publishing Company

Access to resources Recommend Favorite

A Southwest Oncology Group Randomized Phase II Study of Doxorubicin and Paclitaxel as Frontline Chemotherapy for Women with Metastatic Breast Cancer

By Lyman Gary   Green Stephanie   Ravdin Peter   Geyer Charles   Russell Christy   Balcerzak Stanley   Thomas Budd G.   Martino Silvana  

Breast Cancer Research and Treatment, Vol. 85, Iss. 2, 2004-05 ,pp. : 143-150

Springer Publishing Company

Access to resources Recommend Favorite

Primary chemotherapy with doxorubicin and paclitaxel in patients with early breast cancer: final results of a multicenter phase II study

By Schmid P.   Krocker J.   Morack G.   Heilmann V.   Blohmer J.-U.   Michniewicz K.   Köhler G.   Schaller-Kranz T.   Possinger K.   Elling D.  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 11, 2004-11 ,pp. : 657-663

Springer Publishing Company

Access to resources Recommend Favorite